Rare and complex brain disorders present unique challenges for clinicians and researchers due to their heterogeneous nature and the limited understanding of their underlying mechanisms. These disorders, including conditions like cortical dysplasia, rare forms of epilepsy, and neurodegenerative diseases, often require specialized care and treatment plans tailored to the specific needs of each patient. Despite their rarity, the impact of these disorders on patients and their families can be profound, leading to significant physical, cognitive, and emotional challenges. Advances in research are beginning to unravel the genetic and molecular foundations of these conditions, offering hope for the development of more effective therapies. Early detection, better diagnostic tools, and innovative treatments, such as gene therapy and neurostimulation, are paving the way for improved outcomes and quality of life for individuals with rare brain disorders.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States